13 episodes

www.Melody.education is the premier, online central source and community wherein multidisciplinary healthcare providers deliver and experience the most up-to-date information, data and resources on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD). With our Clinical Experts Faculty we produce: Webconferences, Strategies for Optimal Outcomes, Case Studies, Audience Questions and Faculty Answers.

Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD‪)‬ Melody.education

    • Health & Fitness

www.Melody.education is the premier, online central source and community wherein multidisciplinary healthcare providers deliver and experience the most up-to-date information, data and resources on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD). With our Clinical Experts Faculty we produce: Webconferences, Strategies for Optimal Outcomes, Case Studies, Audience Questions and Faculty Answers.

    Keith Miller, PhD presents Part 1: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

    Keith Miller, PhD presents Part 1: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

    Part 1: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD) with Keith Miller, PhD

    • 44 sec
    Christina Hanson, MS, FNP presents Part 2: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

    Christina Hanson, MS, FNP presents Part 2: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

    Part 2: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD) with Christina Hanson, MS, FNP

    • 11 min
    Ann Moore, FNP-C presents Part 3: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

    Ann Moore, FNP-C presents Part 3: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

    Part 3: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD) with Ann Moore, FNP-C

    • 27 min
    Prof Quentin M. Anstee presents Part 1: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

    Prof Quentin M. Anstee presents Part 1: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

    Part 1: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives with Prof Quentin M. Anstee (presented at EASL 2022)

    • 20 min
    Jörn M. Schattenberg, MD presents Part 2: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

    Jörn M. Schattenberg, MD presents Part 2: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

    Part 2: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives with Jörn M. Schattenberg, MD (presented at EASL 2022)

    • 13 min
    Stephen A. Harrison, MD, FACP, FAASLD presents Part 3: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

    Stephen A. Harrison, MD, FACP, FAASLD presents Part 3: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives as presented at EASL 2022

    Part 3: Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives with Stephen A. Harrison, MD, FACP, FAASLD (presented at EASL 2022)

    • 23 min

Top Podcasts In Health & Fitness

Huberman Lab
Scicomm Media
On Purpose with Jay Shetty
Jay Shetty
The Peter Attia Drive
Peter Attia, MD
The Doctor's Farmacy with Mark Hyman, M.D.
Dr. Mark Hyman
Maintenance Phase
Aubrey Gordon & Michael Hobbes
Ten Percent Happier with Dan Harris
Ten Percent Happier